Experts: Cancer drugs remain in short supply, delaying life-saving treatment

At an American Cancer Society meeting, doctors said 75% of pediatric oncology centers in the U.S. don't have enough Methotrexate.

News 12 Staff

Sep 27, 2023, 2:09 PM

Updated 292 days ago

Share:

Experts say cancer drugs remain in short supply, delaying life-saving treatment.
At an American Cancer Society meeting, doctors said 75% of pediatric oncology centers in the U.S. don't have enough Methotrexate.
The chemotherapy drug is used to treat a wide variety of childhood cancers.
Analysts say most of the drugs in short supply do not make a profit, so companies are reluctant to make them.


More from News 12